Eva Rohde

Eva Rohde is a Professor and Head of the University Institute for Transfusion Medicine at Paracelsus Medical University Salzburg. Her research focuses on extracellular vesicles (EVs) in regenerative medicine, SARS-CoV-2 immunology, and stem cell biology. She leads major projects like EV-TT (Extracellular Vesicles Theralytic Technologies Transfer Center) and CONSONANT (Nanovesicle Technologies). Rohde has received awards including the Philip-Levine-Forschungspreis (2021) and multiple Erwin-Domanig Awards.

Her work spans EV-based therapies for spinal cord injuries, hearing loss, and fibrosis prevention. Key projects include clinical trials for umbilical cord-derived EVs and investigations into SARS-CoV-2 reinfection dynamics in blood donors. Rohde also contributes to regulatory standards via initiatives like MISEV2023 guidelines for EV research.

• Over 230 publications since 2003
• 5 concluded research projects (2017–2025)
• Active in conferences like ISCT Scientific Signature Series on EV therapeutics

Research emphasizes translational medicine, combining clinical trials with mechanistic studies on EV functionality and safety. Ongoing work explores EV applications in neuroprotection and tissue regeneration.